.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Harvard Business School
Novartis
US Army
Chubb
Federal Trade Commission
Johnson and Johnson
Teva
Daiichi Sankyo
Medtronic

Generated: December 13, 2017

DrugPatentWatch Database Preview

Naratriptan hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for naratriptan hydrochloride and what is the scope of naratriptan hydrochloride freedom to operate?

Naratriptan hydrochloride
is the generic ingredient in two branded drugs marketed by Glaxosmithkline Llc, Apotex Corp, Heritage Pharms Inc, Mylan Pharms Inc, Orchid Hlthcare, Paddock Llc, Sandoz, Sun Pharm Inds Ltd, Teva Pharms, and West-ward Pharms Int, and is included in ten NDAs. Additional information is available in the individual branded drug profile pages.

There are six drug master file entries for naratriptan hydrochloride. Six suppliers are listed for this compound.

Pharmacology for naratriptan hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
West-ward Pharms IntNARATRIPTANnaratriptan hydrochlorideTABLET;ORAL090381-002Jul 7, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Mylan Pharms IncNARATRIPTANnaratriptan hydrochlorideTABLET;ORAL202431-001May 31, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Heritage Pharms IncNARATRIPTANnaratriptan hydrochlorideTABLET;ORAL200502-001Feb 28, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Paddock LlcNARATRIPTANnaratriptan hydrochlorideTABLET;ORAL091326-002Jul 8, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
SandozNARATRIPTANnaratriptan hydrochlorideTABLET;ORAL090288-001Jul 7, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Sun Pharm Inds LtdNARATRIPTANnaratriptan hydrochlorideTABLET;ORAL091552-001Feb 14, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Heritage Pharms IncNARATRIPTANnaratriptan hydrochlorideTABLET;ORAL200502-002Feb 28, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Glaxosmithkline LlcAMERGEnaratriptan hydrochlorideTABLET;ORAL020763-001Feb 10, 1998ABRXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Orchid HlthcareNARATRIPTANnaratriptan hydrochlorideTABLET;ORAL091441-001Apr 30, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Orchid HlthcareNARATRIPTANnaratriptan hydrochlorideTABLET;ORAL091441-002Apr 30, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: naratriptan hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Glaxosmithkline LlcAMERGEnaratriptan hydrochlorideTABLET;ORAL020763-002Feb 10, 1998► Subscribe► Subscribe
Glaxosmithkline LlcAMERGEnaratriptan hydrochlorideTABLET;ORAL020763-001Feb 10, 1998► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Harvard Business School
Federal Trade Commission
Moodys
Chubb
Baxter
US Department of Justice
Merck
Deloitte
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot